<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14114">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02923141</url>
  </required_header>
  <id_info>
    <org_study_id>20160744</org_study_id>
    <nct_id>NCT02923141</nct_id>
  </id_info>
  <brief_title>Trauma Intervention for Affect Regulation, AIDS, and Substances</brief_title>
  <acronym>TIARAS</acronym>
  <official_title>Trauma Intervention for Affect Regulation, AIDS, and Substances</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Purpose of this study is to see if it is possible to deliver an intervention that
      targets trauma, substance use, and engagement in HIV care with HIV-positive women.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in Human Immunodeficiency Viral load</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in T-helper (CD4+) cell count</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in HIV transmission risk</measure>
    <time_frame>6 months</time_frame>
    <description>self-reported condomless, serodiscordant sex and HIV viral load greater than 200 copies/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in substance use</measure>
    <time_frame>6 months</time_frame>
    <description>self-report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in substance use</measure>
    <time_frame>6 months</time_frame>
    <description>urine toxicology screening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in post-traumatic stress disorder (PTSD) symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>self-report measures: PTSD Checklist for DSM-V</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Human Immunodeficiency Virus</condition>
  <condition>Substance Related Disorder</condition>
  <condition>Post Traumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Neutral Writing + Contingency Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will attend four attention-matched control sessions, consisting of face-to-face administration of psychological measures and neutral writing exercises. Participants will also take part in 36 contingency management sessions in which they provide self-collected urine for toxicology screening and receive financial incentives for each negative drug result.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expressive Writing + Contingency Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will attend four expressive writing sessions focusing on traumatic or stressful events. Participants will also take part in 36 contingency management sessions in which they provide self-collected urine for toxicology screening and receive financial incentives for each negative drug result.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neutral Writing</intervention_name>
    <arm_group_label>Neutral Writing + Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Expressive Writing</intervention_name>
    <arm_group_label>Expressive Writing + Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <arm_group_label>Neutral Writing + Contingency Management</arm_group_label>
    <arm_group_label>Expressive Writing + Contingency Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV positive

          -  woman or trans woman

          -  substance use

          -  elevated PTSD symptoms

          -  HIV care difficulties

        Exclusion Criteria:

          -  not HIV positive

          -  no substance use

          -  men

          -  no HIV care difficulties

          -  no history of trauma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Carrico, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adam Carrico, Ph.D.</last_name>
    <phone>3052436947</phone>
    <email>a.carrico@miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Building</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawdae Thomas-Smith, MD,MPH</last_name>
      <phone>305-243-2278</phone>
      <email>sthomas-smith@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Solace Ehioghae, MBA</last_name>
      <phone>3052432278</phone>
    </contact_backup>
    <investigator>
      <last_name>Adam Carrico, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 28, 2017</lastchanged_date>
  <firstreceived_date>September 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Adam Carrico</investigator_full_name>
    <investigator_title>Associate Professor of Public Health Sciences and Psychology</investigator_title>
  </responsible_party>
  <keyword>substance use</keyword>
  <keyword>trauma</keyword>
  <keyword>HIV</keyword>
  <keyword>viral load</keyword>
  <keyword>women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Immunologic Deficiency Syndromes</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
